Navigation Links
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
Date:4/14/2008

and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cephalon Quarterly Conference Call Invitation
2. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
3. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
4. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
5. Cephalon General Counsel John E. Osborn to Resign Position
6. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
7. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
8. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
9. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
10. Cephalon Submits Supplemental New Drug Application for FENTORA
11. Cephalon Announces Strong Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)...SSAUGA, ON, Dec. 5 /PRNewswire-FirstCall/ - YM Bio...YMBA), an oncology company that identifies, develo...patients worldwide, today reported that Oncoscienc...,s subsidiary, CIMYM BioSciences Inc., has withdra...y (EMEA) for marketing authorization of nimotuzuma...
(Date:12/4/2008)...IEGO, Dec. 4 Favrille, I...ds.com, Inc. ("MMR"), a health,information compan...c Personal,Health Records (PHRs), announced today... closing of their definitive merger agreement have...m/cgi-bin/prnh/20080404/LAF521LOGO ) , "We ...
(Date:12/4/2008)...ership will accelerate research of potential vacci...and GAITHERSBURG, Md., Dec. 4 The ...ofit global health organization PATH announced tod...mic influenza vaccine. PATH will initially invest ...n early-stage development of a H5N1 virus-like par...
(Date:12/4/2008)...YSVILLE, Pa., Dec. 4 Ray...cer of Met-Pro Corporation (NYSE: MPR ), announce...their meeting on December 3, 2008, declared a quar... 12, 2009 to shareholders of record at the close o...presents a 9.1% increase over the same period last...
Breaking Biology Technology:YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 2YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3Met-Pro Corporation Declares Quarterly Dividend 2
...nologies Incorporated has closed its acquisition ...for $6 million in cash. Both companies make medica...ols has renewed through 2010 its deal to buy mana...tworks , a global telecom headquartered near Toron...rcing nearly all the management of their network a...
...ly a banner year for venture capital investments i... MoneyTree report, which is based on data from the...at does this mean for the life science industry? ,...re particularly, what does it mean for the Midwest...l down to this level and find out (I can hear the ...
... Zhang received another boost to his stem-cell res...el J. Fox Foundation . Zhang, an assistant profess...isconsin-Madisons stem-cell research program, will...ns Cell Line II program and will be paid in instal...The work done by Zhangs team centers on finding th...
...t is showing a pulse again, Midwest technology CEO...ering: Which employee is going to surprise them wi... the clock ticking on a two-week notice period? , ...e, its also disconcerting to a manager whos on the...ed integration project or just keep the firms engi...
Other Biology Technology:Life-science sector grabbed VC investment in 2004 2Life-science sector grabbed VC investment in 2004 3Stem-cell research gets grant from M.J. Fox Foundation 2Keep your tech employees happy 2Keep your tech employees happy 3Keep your tech employees happy 4
(Date:12/4/2008)...rium overcomes a tomato plant,s defences and cause...uder detection systems, is,revealed in new resear..., The new study focuses on a pathogen which caus... bacterial invasion causes black lesions on leaves...and costly damage to,tomato crops, and researcher...
(Date:12/4/2008)...half of a person,s body mass consisting of skeleta...hich include those found in the limbs can result ...to University of Illinois kinesiology and communit...s demonstrated that the antioxidant properties of ...n of certain pro-inflammatory cytokines, in vitro,...
(Date:12/4/2008)...earthquakes and destructive tsunamis over the past...nother large earthquake, warns an international gr...shed in the Dec. 4 issue of the journal Nature . ...agnitude 9.2 in December 2004, produced the most w.... The cause of that calamity was the rupture of a...
(Date:12/4/2008)...AA new and improved tool to monitor deforestation ...n a huge boost. The Gordon and Betty Moore Foundat...ent of Global Ecology with a $1.6-million grant to... Analysis System Lite), a new, user-friendly metho...on-governmental organizations (NGOs) to map tropic...
Breaking Biology News(10 mins):Red alert! How disease disables tomato plant's 'intruder alarm' 2Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 3September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3Tropical forest carbon monitoring gets big boost 2Marital Status Doesnt Affect Lung Cancer Survival 1121 1Marital Status Doesnt Affect Lung Cancer Survival 1121 2Marital Status Doesnt Affect Lung Cancer Survival 1121 3Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2405 1Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2405 2Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2405 3Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2405 4Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4 2008 8919 1Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4 2008 8919 2Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4 2008 8919 3Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4 2008 8919 4Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4 2008 8919 5Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 1Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 2
... group of Montreal researchers has discovered that...sion of new information into long-term memory, may...rm to long-term memory. Their paper Translational ...ory by the eIF2a kinase GCN2, which was published ...ovides the first genetic evidence that protein syn...
...olecular motors are nanoscale engines which move a..., drive the heavy traffic of molecular cargo withi...be isolated from the cells and used to construct b...the flux of the cargo transport, it would be neces...ute to this transport but, at the same time, avoid...
...y deciphering the ingenious mechanism used by a pa...mistry, scientists have come a step closer to desi...bacterial infections in their tracks. Their resear...rnal Cell. , Scientists have known for many years ...ferase) plays a role in regulating gene expression...
...ew research on a bacterium that can survive encoun...hened scientists, belief that these plentiful whit...er our immune system will permit or prevent bacter...s released today online in The Journal of Immunolo...atories (RML), part of the National Institute of A...
Other Biology News:Montreal researchers probe the genetic basis of memory 2Motor transport in bio-nano systems 2Motor transport in bio-nano systems 3Motor transport in bio-nano systems 4Scientists take aim at virulent bacteria by decoding machinery of key control enzyme 2Scientists reveal how disease bacterium survives inside immune system cell 2Scientists reveal how disease bacterium survives inside immune system cell 3
I-Ab MHC Class II
...orporates the critical design features demanded by...marker research. The Series 4000 delivers improved...rting biomarker discoveries to biomarker assays al...d to fit into the research plans of any life scien...
BssH II Bacillus stearothermophilus from Sigma-Aldrich
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,369-4) or contact custom
Biology Products: